Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in APGE — Apogee Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in APGE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,617,688
+$2,262,636 QoQ
Shares Held
27,256
+69.3% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#135
of 285 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APGE Over Time

Shares Held

Position Value (USD)

Derivatives in APGE

reported options exposure · as of Jun 30, 2026
CallValue
$9,768,928
CallShares
73,600
PutValue
$26,917,644
PutShares
202,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. APGE ranks #60 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APGE

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,617,688 27,256
2026-06-30 $9,768,928 73,600
2026-06-30 $26,917,644 202,800
2026-03-31 $9,384,955 111,500
2026-03-31 $1,355,052 16,099
2026-03-31 $16,059,636 190,800
2025-12-31 $3,147,516 41,700
2025-12-31 $349,774 4,634
2025-12-31 $5,993,112 79,400
2025-09-30 $663,053 16,689
2025-09-30 $1,549,470 39,000
2025-09-30 $3,162,508 79,600
2025-06-30 $1,680,610 38,697
2025-06-30 $6,631,761 152,700
2025-06-30 $5,163,827 118,900
2025-03-31 $3,160,656 84,600
2025-03-31 $3,336,248 89,300
2025-03-31 $2,627,827 70,338
2024-12-31 $1,417,346 31,288
2024-12-31 $2,409,960 53,200
2024-09-30 $3,026,872 51,530
2024-09-30 $522,786 8,900
2024-09-30 $387,684 6,600
2024-06-30 $595,090 15,123
2024-06-30 $346,280 8,800
2024-03-31 $1,106,924 16,658
2024-03-31 $1,176,165 17,700
2023-12-31 $264,899 9,481